Literature DB >> 7343168

Treatment of malignant melanoma by intravascular 4-hydroxyanisole.

B D Morgan, T O'Neill, D L Dewey, A R Galpine, P A Riley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7343168

Source DB:  PubMed          Journal:  Clin Oncol        ISSN: 0305-7399


× No keyword cloud information.
  5 in total

1.  Possible genotoxicity of melanin synthesis intermediates: tyrosinase reaction products interact with DNA in vitro.

Authors:  M Miranda; D Botti; M Di Cola
Journal:  Mol Gen Genet       Date:  1984

2.  Ribonucleotide reductase in melanoma tissue. EPR detection in human amelanotic melanoma and quenching of the tyrosine radical by 4-hydroxyanisole.

Authors:  G Lassmanm; B Liermann; W Arnold; K Schwabe
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 3.  Actinobacterial melanins: current status and perspective for the future.

Authors:  Panchanathan Manivasagan; Jayachandran Venkatesan; Kannan Sivakumar; Se-Kwon Kim
Journal:  World J Microbiol Biotechnol       Date:  2013-04-18       Impact factor: 3.312

4.  Ultrastructural and biochemical observations on the effect of 4-hydroxyanisole plus tyrosinase on normal human melanocytes and keratocytes in tissue culture.

Authors:  A Breathnach; E Robins; L Ethridge; Y Bhasin; S Gallagher; S Passi; M Nazzaro-Porro
Journal:  Br J Cancer       Date:  1983-06       Impact factor: 7.640

5.  The treatment of animal tumours and their metastases with 4-hydroxyanisole.

Authors:  A Kanclerz; J D Chapman
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.